Cargando…

Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population

BACKGROUND: Age-specific prostate specific antigen (PSA) cutoffs for prostate biopsy have been widely used in the USA and European countries. However, the application of age-specific PSA remains poorly understood in China. METHODS: Between 2003 and 2012, 1,848 men over the age of 40, underwent prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Rong, Wu, Yishuo, Xu, Jianfeng, Jiang, Haowen, Ding, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692456/ https://www.ncbi.nlm.nih.gov/pubmed/23825670 http://dx.doi.org/10.1371/journal.pone.0067585

Ejemplares similares

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Plasma genistein and risk of prostate cancer in Chinese population
por: Wu, Yishuo, et al.
Publicado: (2015)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml
por: Chen, Rui, et al.
Publicado: (2015)

Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation
por: Hsieh, Teng-Fu, et al.
Publicado: (2023)

Clinically available RNA profiling tests of prostate tumors: utility and comparison
por: Na, Rong, et al.
Publicado: (2016)

A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort
por: Lin, Xiaoling, et al.
Publicado: (2021)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)

The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
por: Liu, Shenghua, et al.
Publicado: (2015)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020)

Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?
por: Tsang, Chiu-Fung, et al.
Publicado: (2019)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?
por: Teoh, Jeremy YC, et al.
Publicado: (2015)

Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases
por: Na, Rong, et al.
Publicado: (2016)

Prostate-specific antigen cutoff value for ordering sodium fluoride positron emission tomography/computed tomography bone scan in patients with prostate cancer
por: Sarikaya, Ismet, et al.
Publicado: (2018)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
por: Ganpule, Arvind P., et al.
Publicado: (2007)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
por: Cabarkapa, Sonja, et al.
Publicado: (2016)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population
por: Xu, Chenyang, et al.
Publicado: (2020)

Is Prostate Biopsy Essential to Diagnose Prostate Cancer in the Older Patient with Extremely High Prostate-Specific Antigen?
por: Jang, Jee Young, et al.
Publicado: (2012)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
por: Nordström, Tobias, et al.
Publicado: (2017)

The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure
por: Yang, Tian, et al.
Publicado: (2017)

Prostate specific antigen /
Publicado: (2001)

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
por: Lott, Felipe
Publicado: (2020)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
por: Xie, Gan-Sheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oogkl1qm8tmrqldnae8u1oblch